General | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Comparison | ||||||||||||||||||||||||||||
|
Date | For | Estimate | Reported | Surprise | surprise % |
---|---|---|---|---|---|
2024-04-26 | 2024-01 | -8.99 | N/A | N/A | N/A |
2023-11-30 | 2023-10 | -7.18 | N/A | N/A | N/A |
2023-09-06 | 2023-07 | -11.07 | N/A | N/A | N/A |
2023-05-24 | 2023-04 | -15.8 | N/A | N/A | N/A |
2023-03-24 | 2023-01 | -14.4 | N/A | N/A | N/A |
2022-12-08 | 2022-10 | -5.8 | N/A | N/A | N/A |
Date | Name | Relation | Quantity | Description |
---|---|---|---|---|
2022-06-07 | ARCHBOLD MICHAEL G | Director | 218.45K | Stock Award(Grant) |
2022-06-07 | DAVENPORT TERRY D. | Director | 188.89K | Stock Award(Grant) |
2022-06-07 | DEVINE MICHAEL F III | Director | 222.64K | Stock Award(Grant) |
2022-06-07 | LEEVER KAREN | Director | 190.78K | Stock Award(Grant) |
2022-06-07 | LOPEZ-GARCIA PATRICIA E | Director | 46.58K | Stock Award(Grant) |
2022-06-07 | LUCIO ANTONIO J. | Director | 56.17K | Stock Award(Grant) |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Vanguard Group Inc | 169.94K | 2.02M | 4.54% |
2023-06-29 | Royce & Associates LP | 94.39K | 1.12M | 2.52% |
2023-06-29 | Invesco Ltd. | 54.00K | 640.88K | 1.44% |
2023-06-29 | Gratia Capital, LLC | 48.01K | 569.76K | 1.28% |
2023-06-29 | Blackrock Inc. | 47.68K | 565.87K | 1.27% |
2023-06-29 | Renaissance Technologies, LLC | 39.17K | 464.81K | 1.05% |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Vanguard Total Stock Market Index Fund | 112.67K | 1.34M | 3.01% |
2023-06-29 | Royce Opportunity Fund | 60.55K | 718.55K | 1.62% |
2023-08-30 | Invesco ETF Tr-Invesco FTSE RAFI US 1500 Small-Mid ETF | 53.86K | 543.42K | 1.44% |
2023-06-29 | Vanguard Extended Market Index Fund | 50.96K | 604.78K | 1.36% |
2023-05-30 | Fidelity Extended Market Index Fund | 17.34K | 197.85K | 0.46% |
2023-05-30 | Vanguard Russell 2000 Index Fund | 8.65K | 98.67K | 0.23% |
Dividend | Date |
---|---|
0.56 | 2010-12-14 |
Split | Date |
---|---|
1 : 20 | 2023-08-31 |
Revenue per share is 23$+
Super discounted company.
$EXPR LONG
5$ by spring of 2021!!!
Fear only works on those that donâ€t research companies.
When you understand completely fundamentals you realize falls and dips are buying opportunities!!!
$EXPR 2.5$ beoy
LONG
EXPR HEADING BACK TO 11$
Where it should be trading.
COMPLETELY OVER SOLD!!
Just remember this company.s market cap is 17 million with 400-500 million in annual revenue!!
Do people not read?
At 3.50$ the company had a 178 million dollar market cap!!
AND STILL OVERSOLD AND UNDERVALUED!!
$DXLG LONG
$DXLG POPPING TODAY!!
Go baby go!!
It is an improvement over Q1 numbers.
Basically it’s a step in the right direction and it sounds like the company is acting responsibly. Interested to see what Q3 looks like. If the numbers continue to improve.
These numbers were to be expected.
Quite frankly I’m glad they did as well as they did all things considered.
Purchased more today.
Loading up.
Sale get rid of old inventory to make room for next season.
Uh Fall and winter.
Unless you like wearing shorts in the snow!
This stock should be trading between
8-12$ a share!!
Oversold
Undervalued
Going to make people a lot of money!!
$EXPR LONG
SEE YOU AT 10$ a share 2021
@6$ a share this is only a 420 million dollar market cap!!
Over a billion dollars in revenue last year.
I get it times are tough, but a 70 million dollar market cap!?!
I think this stock is severely under valued!
$EXPR LONG
SEE YOU AT 6$ a share!!
PEOPLE WILL BE BACK IN OFFICE BUILDINGS BY SPRING OF 2021!!
Vaccine will be found by NOV
Retail spending will keep increasing as economy improves.
In less than 5 years this stock will be at
12$+ a share
$EXPR LONG
Looks like we hit bottom and are consolidating.
In less than 2 weeks this stock will RUN
EVEN POP!!
2.50$+
$EXPR LONG
This will bounce of 52 week low
Shit stock. I’m gone